Mirae Asset Global ETFs Holdings’s MBX Biosciences MBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$398K Buy
13,325
+67
+0.5% +$2.28K ﹤0.01% 1998
2025
Q4
$418K Buy
13,258
+6,138
+86% +$149K ﹤0.01% 1973
2025
Q3
$125K Sell
7,120
-2,209
-24% -$29.5K ﹤0.01% 2567
2025
Q2
$106K Buy
9,329
+2,682
+40% +$27.3K ﹤0.01% 2580
2025
Q1
$49.1K Buy
6,647
+312
+5% +$3.3K ﹤0.01% 2856
2024
Q4
$117K Buy
+6,335
New +$135K ﹤0.01% 2640

Other funds holding MBX

Mirae Asset Global ETFs Holdings's MBX Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its MBX Biosciences (MBX) stake by 0.51% in Q1 2026, buying an estimated $2.28K and bringing the position to 13,325 shares worth $398K. The position accounts for ﹤0.01% of the portfolio, ranked #1998.

Mirae Asset Global ETFs Holdings first reported a position in MBX in Q4 2024 and has held it in 6 quarters since. The position peaked at $418K in Q4 2025. 157 funds tracked by Wall St. Rank hold MBX as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 13,325 shares of MBX Biosciences worth $398K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 67 MBX Biosciences shares in Q1 2026, an estimated $2.28K.
  • MBX Biosciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1998 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in MBX Biosciences in Q4 2024 and has held it in 6 quarters since.
  • Mirae Asset Global ETFs Holdings's MBX Biosciences position peaked at $418K in Q4 2025.
  • 157 funds tracked by Wall St. Rank held MBX Biosciences as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.